Astonea Labs Ltd Submits FY26 Annual Report
Astonea Labs Ltd has submitted its Annual Report for the Financial Year 2025-26, as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The report, approved by the Board on July 24, 2026, includes the Notice for the 9th Annual General Meeting, Board's Report, Audited Financial Statements, and Statutory Auditors' Report. The company focuses on holistic wellness and anti-aging through pharmaceuticals and nutraceuticals, emphasizing innovation, research, and development. The report details business segments, vision, mission, values, product portfolio, manufacturing capabilities, leadership, governance, financial performance, strategic growth plans, risk management, and CSR initiatives. It also contains detailed financial statements and shareholder information.
Key Highlights
- Astonea Labs Ltd filed its Annual Report for FY 2025-26.
- Report includes financial statements and auditor's report.
- Company focuses on pharmaceuticals, nutraceuticals, and wellness.
- Details on innovation, growth strategy, and future roadmap provided.
- Corporate governance and CSR initiatives are also covered.
Price Impact
More from ASTONEALAB